116 related articles for article (PubMed ID: 3422191)
1. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
Dowding CR; Gordon MY; Goldman JM
Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
3. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
Robak T
Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543
[TBL] [Abstract][Full Text] [Related]
4. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
6. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
[TBL] [Abstract][Full Text] [Related]
7. Discordant expression of human Ia-like antigens on hematopoietic progenitor cells.
Linch DC; Nadler LM; Luther EA; Lipton JM
J Immunol; 1984 May; 132(5):2324-9. PubMed ID: 6609195
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
9. Variable expression of Qa-m7, Qa-m8, and Qa-m9 antigenic determinants on primitive hemopoietic precursor cells.
Harris RA; Sandrin MS; Sutton VR; Hogarth PM; McKenzie IF; Penington DG
J Cell Physiol; 1985 Jun; 123(3):451-8. PubMed ID: 2580849
[TBL] [Abstract][Full Text] [Related]
10. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
[TBL] [Abstract][Full Text] [Related]
11. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
12. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
Tong J; Hoffman R; Siena S; Srour EF; Bregni M; Gianni AM
Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
[TBL] [Abstract][Full Text] [Related]
13. Primitive progenitor cells in the blood of patients with chronic granulocytic leukemia.
Dowding CR; Gordon MY; Goldman JM
Int J Cell Cloning; 1986 Sep; 4(5):331-40. PubMed ID: 3464657
[TBL] [Abstract][Full Text] [Related]
14. Physical, phenotypic and cytochemical characterisation of stroma-adherent blast colony-forming cells.
Dowding CR; Gordon MY
Leukemia; 1992 Apr; 6(4):347-51. PubMed ID: 1588797
[TBL] [Abstract][Full Text] [Related]
15. Effects of S-phase-specific agents on granulocyte-macrophage and erythroid progenitor cells obtained from normal individuals and from patients with chronic myelogenous leukemia.
Kubota K; Preisler HD; Costanzo C
Cancer Res; 1983 Aug; 43(8):3927-31. PubMed ID: 6574819
[TBL] [Abstract][Full Text] [Related]
16. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
Kubota K; Preisler HD; Costanzo C; Miura Y
Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
18. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines.
Bruno E; Luikart SD; Long MW; Hoffman R
Exp Hematol; 1995 Oct; 23(11):1212-7. PubMed ID: 7556532
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD11, CDw15, and transferrin receptor antigens on human hematopoietic progenitor cells.
Falkenburg JH; Koning F; Duinkerken N; Fibbe WE; Voogt PJ; Jansen J
Exp Hematol; 1986 Feb; 14(2):90-6. PubMed ID: 3002833
[TBL] [Abstract][Full Text] [Related]
20. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
